Sharps Technology, Inc. is a forward-thinking company specializing in medical devices and pharmaceutical packaging. The firm is dedicated to developing and manufacturing cutting-edge drug delivery systems designed to enhance safety and efficiency in healthcare settings. One of its key areas of innovation lies in low-waste and ultra-low-waste syringe technologies, which integrate both passive and active safety mechanisms to minimize risks for healthcare professionals and patients alike.
With the rising demand for safer and more efficient medical tools, Sharps Technology has positioned itself as a leader in the industry by focusing on precision, sustainability, and technological advancements. Its syringe systems are engineered to reduce medication waste, an essential factor in pharmaceutical cost management and resource conservation. Additionally, these designs help prevent needle-stick injuries and cross-contamination, addressing critical safety concerns in hospitals, clinics, and other medical environments.
The company was established on December 16, 2017, by industry professionals Alan R. Blackman and Barry B. Berler. Headquartered in Melville, New York, Sharps Technology continues to push the boundaries of syringe innovation, developing solutions that meet the evolving needs of the global healthcare sector.
As regulatory standards become more stringent and the demand for improved drug delivery methods grows, Sharps Technology is poised to play a significant role in shaping the future of medical device manufacturing. By combining cutting-edge research with practical applications, the company remains committed to enhancing patient care, reducing medical waste, and ensuring safety across the healthcare industry.
